泰格医药 (300347.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(泰格医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 5,067,615,359.893,358,244,223.391,660,204,321.447,384,039,460.885,650,477,938.013,710,850,371.591,804,571,375.28
 营业收入(元) 5,067,615,359.893,358,244,223.391,660,204,321.447,384,039,460.885,650,477,938.013,710,850,371.591,804,571,375.28
二、营业总成本(元) 4,026,550,519.062,626,269,846.321,305,287,804.375,554,124,713.544,142,186,555.142,720,025,504.931,360,291,377.24
 营业成本(元) 3,097,333,423.232,025,196,633.701,032,080,670.154,535,510,632.923,370,920,132.802,229,763,452.351,089,048,900.22
 研发费用(元) 172,098,760.28124,694,222.8563,906,152.52261,555,130.31195,343,150.53128,082,457.8264,519,361.97
 营业税金及附加(元) 22,385,614.1414,493,882.327,700,539.0027,866,690.1421,435,986.0314,804,829.176,849,492.11
 销售费用(元) 144,935,323.39101,377,890.5046,452,309.63187,314,822.95132,703,603.9388,998,358.3144,911,069.53
 管理费用(元) 558,426,318.44376,615,946.18177,068,490.82650,201,401.07527,543,104.76346,470,988.24170,923,614.77
 财务费用(元) 31,371,079.58-16,108,729.23-21,920,357.75-108,323,963.85-105,759,422.91-88,094,580.96-15,961,061.36
  其中:利息费用(元) -67,432,236.02-119,897,366.25-52,814,698.13-
  其中:利息收入(元) -71,381,356.68-229,848,679.61-122,538,479.23-
三、其他经营收益
 加:公允价值变动收益(元) -34,411,947.15-98,403,141.0612,753,272.78352,770,634.28710,394,312.74529,757,595.42176,412,728.63
 加:投资收益(元) 109,158,171.3870,743,456.58-3,591,151.18338,175,307.12127,735,432.8998,902,116.9325,784,682.29
  其中:对联营企业和合营企业的投资收益(元) -44,095,071.11-105,183,014.33-63,724,392.56-
 资产处置收益(元) 2,674,931.251,489,722.711,152,370.67-188,092.6745,215.63-5,900.81-3,540.15
 资产减值损失(元) -10,657,299.51-8,424,529.23-7,752,329.78-29,725,239.12-11,764,401.66-8,218,437.27-5,491,837.06
 信用减值损失(元) -44,439,217.18-27,659,162.33-10,652,196.93-38,372,976.88-33,579,759.28-21,559,038.29-15,237,624.14
 其他收益(元) 21,606,421.2717,348,696.4815,369,745.7834,366,177.3510,602,089.438,896,585.585,153,375.29
四、营业利润(元) 1,084,995,900.89687,069,420.22362,196,228.412,486,940,557.422,311,724,272.621,598,597,788.22630,897,782.90
 加:营业外收入(元) 5,337,204.284,950,417.77301,243.1513,453,970.776,871,087.044,549,742.46848,031.87
 减:营业外支出(元) 3,268,133.421,926,665.02133,267.6111,861,470.034,125,944.614,002,437.68683,686.74
五、利润总额(元) 1,087,064,971.75690,093,172.97362,364,203.952,488,533,058.162,314,469,415.051,599,145,093.00631,062,128.03
 减:所得税费用(元) 183,929,494.79132,514,479.0549,793,830.56338,606,214.59286,622,443.31191,055,100.2662,736,467.76
六、净利润(元) 903,135,476.96557,578,693.92312,570,373.392,149,926,843.572,027,846,971.741,408,089,992.74568,325,660.27
(一)按经营持续性分类
  持续经营净利润(元) 903,135,476.96557,578,693.92312,570,373.392,149,926,843.572,027,846,971.741,408,089,992.74568,325,660.27
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 813,428,915.46492,848,850.97235,072,002.702,024,849,989.111,879,604,430.161,388,337,006.20568,455,092.87
  少数股东损益(元) 89,706,561.5064,729,842.9577,498,370.69125,076,854.46148,242,541.5819,752,986.54-129,432.60
 扣除非经常性损益后的净利润(元) 892,098,006.45640,325,126.32303,052,196.141,477,242,053.321,198,424,790.09793,474,391.71381,217,753.93
七、每股收益
 一、基本每股收益(元) 0.940.570.272.342.171.610.66
 二、稀释每股收益(元) 0.940.570.272.342.171.610.66
八、其他综合收益(元) -50,709,884.36-30,370,935.25-22,239,213.9153,516,065.6966,970,735.88103,163,104.24-46,553,885.08
 归属于母公司股东的其他综合收益(元) -26,157,226.69-12,320,083.43-7,569,853.7137,983,160.7341,438,207.7169,870,509.83-30,860,474.07
 归属于少数股东的其他综合收益(元) -24,552,657.67-18,050,851.82-14,669,360.2015,532,904.9625,532,528.1733,292,594.41-15,693,411.01
九、综合收益总额(元) 852,425,592.60527,207,758.67290,331,159.482,203,442,909.262,094,817,707.621,511,253,096.98521,771,775.19
 归属于母公司所有者的综合收益总额(元) 787,271,688.77480,528,767.54227,502,148.992,062,833,149.841,921,042,637.871,458,207,516.03537,594,618.80
 归属于少数股东的综合收益总额(元) 65,153,903.8346,678,991.1362,829,010.49140,609,759.42173,775,069.7553,045,580.95-15,822,843.61
公告日期 2024-10-302024-08-292024-04-262024-03-292023-10-282023-08-262023-04-26
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院